Masthoff, Max 1990-
Max Masthoff researcher
VIAF ID: 316510511 ( Personal )
Permalink: http://viaf.org/viaf/316510511
Preferred Forms
- 100 1 _ ‡a Masthoff, Max ‡d 1990-
- 100 0 _ ‡a Max Masthoff ‡c researcher
4xx's: Alternate Name Forms (1)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
18F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD) | |
Diffusion-Weighted Imaging Prior to Percutaneous Sclerotherapy of Venous Malformations—Proof of Concept Study for Prediction of Clinical Outcome | |
Gorham–Stout disease: good results of bisphosphonate treatment in 6 of 7 patients | |
Highly shifted Protonenbildgebung als neue MR-Technik für Cell-Tracking-Studien | |
In vivo imaging of microenvironmental and anti-PD-L1-mediated dynamics in cancer using S100A8/S100A9 as an imaging biomarker | |
Invasive diagnostic and therapeutic measures are unnecessary in patients with symptomatic van Neck–Odelberg disease (ischiopubic synchondrosis): a retrospective single-center study of 21 patients with median follow-up of 5 years | |
Multiparametric MRI enables for differentiation of different degrees of malignancy in two murine models of breast cancer | |
Radiomics of Tumor Heterogeneity in 18F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer | |
Repeated radioembolization in advanced liver cancer | |
S100A9-Imaging Enables Estimation of Early Therapy-Mediated Changes in the Inflammatory Tumor Microenvironment | |
Tracking of tumor cell-derived extracellular vesicles in vivo reveals a specific distribution pattern with consecutive biological effects on target sites of metastasis |